News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Bristol Myers Squibb Company
NEWS
JOBS
IN THE PRESS
NEWS
FDA
FDA Grants Accelerated Approval for Bristol-Myers Squibb Company’s Skin Cancer Drug Opdivo
December 23, 2014
·
2 min read
Job Trends
Bristol-Myers Squibb Company Reportedly Laid Off Nearly 1,000 Employees In China
December 2, 2014
·
2 min read
Drug Development
FDA Requires Additional Data On Bristol-Myers Squibb Company’ Hep C Daclatasvir
November 26, 2014
·
1 min read
Job Trends
Bristol-Myers Squibb Company To Create Up To 400 New Jobs As Part Of A $900 Million Investment
November 14, 2014
·
2 min read
BioCapital
Bristol-Myers Squibb Company, Merck & Co. Competing Hodgkin’s Drugs Look Comparable, Says Analyst
November 6, 2014
·
1 min read
Business
Bristol-Myers Squibb Strikes Deal Worth $444 Million With Galecto Biotech
November 3, 2014
·
2 min read
Business
Bristol-Myers Squibb Company Forges $475 Million Pact For Rights To f-Star’s Cancer Drug
October 28, 2014
·
2 min read
Pharm Country
Bristol-Myers Squibb Company Sheds $1.4B In Pension Liabilities By Transferring Risk To Prudential
October 1, 2014
·
1 min read
Biotech Bay
Gilead Sciences, Inc. Looks To Erase Bristol-Myers Squibb Company’s Early Hep C Lead
September 30, 2014
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
December 22, 2025
·
10 min read
Press Releases
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026
December 18, 2025
·
1 min read
Press Releases
Bristol Myers Squibb Canada Welcomes Positive CDA Recommendation for OPDIVO® Plus YERVOY® as First-Line Treatment for MSI-H/dMMR Metastatic Colorectal Cancer
December 17, 2025
·
5 min read
Press Releases
U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb’s Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma
December 12, 2025
·
19 min read
Press Releases
Quebec becomes first province in Canada to list new subcutaneous OPDIVO® on public drug plan for solid tumour indications
December 12, 2025
·
4 min read
Press Releases
Bristol Myers Squibb Announces Dividend Increase - December 10, 2025
December 11, 2025
·
1 min read
Press Releases
BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer
December 10, 2025
·
15 min read
Press Releases
Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025
December 9, 2025
·
19 min read
Press Releases
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)
December 5, 2025
·
19 min read
Press Releases
Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer’s Disease
December 3, 2025
·
4 min read
